✦ LIBER ✦

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer

✍ Scribed by Nathan W. D. Lamond, Chris Skedgel, Daniel Rayson, Lynn Lethbridge, Tallal Younis

Book ID: 113062435
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 462 KB
Volume: 133
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-1989-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective clinical utility and pharm

A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer

✍ Davidson, J.A.; Cromwell, I.; Ellard, S.L.; Lohrisch, C.; Gelmon, K.A.; Shenkier 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 458 KB

The impact of the 21-gene Recurrence Sco

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients

✍ Salomon M. Stemmer, Shmuel H. Klang, Noa Ben-Baruch, David B. Geffen, Mariana St 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 348 KB

Cost-effectiveness of a 21-gene recurren

Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer

✍ Malek B Hannouf, Bin Xie, Muriel Brackstone, Gregory S Zaric 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 314 KB

Association Between the 21-Gene Recurren

Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

✍ Mamounas, E. P.; Tang, G.; Fisher, B.; Paik, S.; Shak, S.; Costantino, J. P.; Wa 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 256 KB

Complementing Ipsilateral Breast Tumor R

Complementing Ipsilateral Breast Tumor Recurrence (IBTR!) Estimates With the 21-Gene Recurrence Score (RS) in Early-Stage, Hormone Receptor-Positive, HER2-Normal, Lymph Node-Negative Breast Cancers

✍ Thaker, N.; Hoffman, K.E.; Pusztai, L.; Buchholz, T.A.; Woodward, W.A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Comparison of the prognostic and predict

Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20

✍ Gong Tang; Steven Shak; Soonmyung Paik; Stewart J. Anderson; Joseph P. Costantin 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 460 KB